Xencor (XNCR) Tax Provisions (2016 - 2026)
Xencor (XNCR) reported Tax Provisions of $280000.0 for Q1 2026, down 30.0% year-over-year from $400000.0 in Q1 2025, and down 88.35% quarter-over-quarter from $2.4 million in Q4 2025.
Xencor (XNCR) Tax Provisions (2016 - 2026) Analysis & Trends
Xencor (XNCR) has 8 years of Tax Provisions data on file, last reported at $280000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $280000.0, down 30.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 18.2% YoY), and the FY2025 annual result was $2.5 million, up 54.85% from the prior year.
- Tax Provisions fell to $280000.0 in Q1 2026 per XNCR's latest filing, from $2.4 million in the prior quarter.
- Over five years, Tax Provisions peaked at $13.7 million in Q4 2023 and troughed at -$415000.0 in Q4 2022.
- A 5-year average of $2.3 million and a median of $744000.0 in 2022 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions soared 3392.05% in 2023, then plunged 88.16% in 2024.
- A 5-year view of Tax Provisions shows it stood at -$415000.0 in 2022, then soared by 3392.05% to $13.7 million in 2023, then sank by 88.16% to $1.6 million in 2024, then jumped by 48.67% to $2.4 million in 2025, then sank by 88.35% to $280000.0 in 2026.
- Business Quant data shows XNCR's Tax Provisions at $280000.0 in Q1 2026, $2.4 million in Q4 2025, and -$300000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 280,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 280,000.00 |
| Dec 31, 2025 | 2.40 Mn |
| Jun 30, 2025 | -300,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 13.66 Mn |
| Dec 31, 2022 | -415,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Dec 31, 2019 | -288,000.00 |
| Sep 30, 2019 | -350,000.00 |
| Jun 30, 2019 | 50,000.00 |
| Mar 31, 2019 | 900,000.00 |
| Dec 31, 2017 | -1.12 Mn |
| Sep 30, 2017 | 173,000.00 |
| Jun 30, 2017 | 280,000.00 |
| Mar 31, 2017 | 170,000.00 |
| Dec 31, 2016 | -159,000.00 |
| Sep 30, 2016 | -598,000.00 |
| Jun 30, 2016 | 1.75 Mn |